Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume -, Issue -, Pages 2007557
Publisher
Wiley
Online
2021-01-16
DOI
10.1002/adma.202007557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation
- (2020) Guangzhi Li et al. ACS Nano
- Immune-related adverse events and outcomes during treatment with immune checkpoint inhibitors in non-small cell lung cancer (NSCLC) patients.
- (2020) Javier López Gallego et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy
- (2020) Zhaoting Li et al. Science Advances
- Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
- (2019) Asha Kumari Patel et al. ADVANCED MATERIALS
- Immunotherapy: a new era in small-cell lung cancer
- (2019) Thorsten Oliver Goetze LANCET
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
- (2018) Hadeer M. Abdelaziz et al. JOURNAL OF CONTROLLED RELEASE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study
- (2018) Weikai Xiao et al. Cancer Medicine
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- The potential to treat lung cancer via inhalation of repurposed drugs
- (2018) Wing-Hin Lee et al. ADVANCED DRUG DELIVERY REVIEWS
- Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy
- (2018) Caina Xu et al. JOURNAL OF CONTROLLED RELEASE
- Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases
- (2017) Gino Van Heeke et al. PHARMACOLOGY & THERAPEUTICS
- Chitosan: An Adjuvant with an Unanticipated STING
- (2016) Nicolas Riteau et al. IMMUNITY
- The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
- (2016) Elizabeth. C. Carroll et al. IMMUNITY
- Nanotechnology for protein delivery: Overview and perspectives
- (2016) Mikyung Yu et al. JOURNAL OF CONTROLLED RELEASE
- Tight junctions: from simple barriers to multifunctional molecular gates
- (2016) Ceniz Zihni et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
- (2014) Virginie Hervé et al. mAbs
- Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1
- (2013) L. S. Rodgers et al. JOURNAL OF CELL SCIENCE
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors
- (2012) Faruk Tas Journal of Oncology
- Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening
- (2011) Tzyy-Harn Yeh et al. BIOMATERIALS
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
- (2011) Agnès Maillet et al. PHARMACEUTICAL RESEARCH
- Treatment options for small cell lung cancer – do we have more choice?
- (2010) M Puglisi et al. BRITISH JOURNAL OF CANCER
- Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution
- (2010) Driton Vllasaliu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search